Insmed Up Over 30% Following FDA Decision

By: via Benzinga
Insmed (NASDAQ: INSM) shareholders are having a big day. Shares are up over 33 percent after the company announced that the FDA ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.